CRP and colorectal cancer: There are numerous reports indicating the usefulness of hematology-associated inflammatory markers such as platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), lymphocyte-to-leukocyte ratio (LWR), neutrophil-to-monocyte ratio (NMR), and lymphocyte-to-CRP ratio (LCR) in colorectal cancer prognosis and therapy monitoring [34].